ESERX
Price
$27.07
Change
-$0.31 (-1.13%)
Updated
Sep 9 closing price
Net Assets
232.38M
RGAEX
Price
$86.88
Change
-$0.27 (-0.31%)
Updated
Sep 9 closing price
Net Assets
353.07B
Interact to see
Advertisement

ESERX vs RGAEX

ESERX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
ESERX vs. RGAEX commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESERX is a Hold and RGAEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 353B vs. ESERX (232M). RGAEX pays higher dividends than ESERX: RGAEX (0.21) vs ESERX (0.00). ESERX was incepted earlier than RGAEX: ESERX (10 years) vs RGAEX (24 years). ESERX (0.76) is less costly to investors than RGAEX (0.63). RGAEX is a more actively managed with annual turnover of: 32.00 vs. ESERX (12.00). RGAEX has a lower initial minimum investment than ESERX: RGAEX (250) vs ESERX (5000000). RGAEX annual gain was more profitable for investors over the last year : 1.41 vs. ESERX (-22.92). RGAEX return over 5 years is better than : 13.46 vs. ESERX (-21.12).
ESERXRGAEXESERX / RGAEX
Total Expense Ratio0.750.63119%
Annual Report Gross Expense Ratio0.760.63121%
Fund Existence10 years24 years-
Gain YTD-6.6489.517-70%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets232M353B0%
Annual Yield % from dividends0.000.21-
Returns for 1 year-22.921.41-1,626%
Returns for 3 years-12.4443.64-29%
Returns for 5 years-21.1213.46-157%
Returns for 10 yearsN/A106.36-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOAX72.81N/A
N/A
Rydex Biotechnology H
FDTEX40.73N/A
N/A
Fidelity Advisor Diversified Stock M
VLISX733.69N/A
N/A
Vanguard MStar Large Cap Index Instl
GEICX6.58N/A
N/A
Gabelli Equity Income C
AVENX18.34-0.06
-0.33%
Avantis® Emerging Markets Equity G